Tavira Therapeutics

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 800197.8,
      "delta_eur": 800197.8,
      "before_eur": 0.0,
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 80019,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 10.0
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 800197.8,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 1050197.8,
      "delta_eur": 250000.0,
      "before_eur": 800197.8,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 25000,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 10.0
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 250000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": 1050197.8,
      "delta_eur": null,
      "before_eur": 1050197.8,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "Incentive Inschrijvingsrechten",
        "n_new_shares": 11669,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "statutory_reserve_release",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    }
  ],
  "notary": {
    "name": "Emma Liekens",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2025-11-05",
    "filing_date": "2025-11-03",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2025-10-30",
    "unanimous": true,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "EY Bedrijfsrevisoren BV",
    "ibr_number": null,
    "mission_type": "quasi_apport",
    "individual_name": "Eef Naessens"
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "Tavira Therapeutics",
    "legal_form": "B.V.",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": null,
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition van de akte en de geco\u00F6rdineerde tekst van de statuten met de lijst van de oprichtings en wijzigende akten",
    "verslagen van het bestuursorgaan en de commissaris"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 800197.8,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 800197.8,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-10-30",
      "evidence_quote": "de beschikbare eigen vermogensrekening van de vennootschap verhoogd werd met een bedrag van achthonderdduizend honderdzevenennegentig komma tachtig euro (\u20AC800.197,80) door uitgifte van tachtigduizend negentien (80.019) aandelen, zonder nominale waarde, deelnemend in de winst vanaf hun onderschrijving, vertegenwoordigend \u00E9\u00E9n/tweehonderd achtenzeventigduizend negentiende (1/278.019de) van het vennootschapsvermogen, en waarop ingetekend werd door een inbreng in natura van een schuldvordering ten belope van zulk bedrag aan een uitgifteprijs van afgerond tien euro (\u20AC10,00) per aandeel, welke aandelen voor honderd procent (100%) volgestort werden.",
      "contribution_type": "in_kind"
    },
    {
      "kind": "capital_increase",
      "amount": 250000.0,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 250000.0,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2025-10-30",
      "evidence_quote": "de beschikbare eigen vermogensrekening van de vennootschap verhoogd werd met een bedrag van tweehonderdvijftigduizend euro (\u20AC250.000,00) door uitgifte van vijfentwintigduizend (25.000) aandelen, zonder nominale waarde, deelnemend in de winst vanaf hun onderschrijving, vertegenwoordigend \u00E9\u00E9n/driehonderdendrieduizend negentiende (1/303.019de) van het vennootschapsvermogen, en waarop ingetekend werd door een inbreng speci\u00EBn ten belope van zulk bedrag aan een uitgifteprijs van tien euro (\u20AC10,00) per aandeel, welke aandelen voor honderd procent (100%) volgestort werden.",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "TAVIRA THERAPEUTICS",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Eef Naessens",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "EY Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2024-11-25",
      "evidence_quote": "Het bestuursorgaan beslist op 25 november 2024 om EY Bedrijfsrevisoren BV, met maatschappelijke zetel te 1831 Diegem, Kouterveldstraat 7B bus 001, vertegenwoordigd door mevrouw Eef Naessens, 1831 Diegem, Kouterveldstraat 7B bus 001bedrijfsrevisor, te benoemen tot commissaris, voor een termijn van dr"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "TAVIRA THERAPEUTICS",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "EY Bedrijfsrevisoren BV",
        "address": "1831 Diegem, Kouterveldstraat 7B bus 001",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": true,
      "effective_date": "2024-11-25",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "3"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2024-11-25",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-11-25",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "Tavira Therapeutics",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "org",
    "org_kbo": null,
    "org_name": "MichaEls Management BV",
    "person_name": null,
    "org_rep_person_name": "Els Henckaerts",
    "person_role_at_subject": null
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Leuven",
        "region": "Vlaams Gewest",
        "street": "Gaston Geenslaan",
        "country": "BE",
        "postcode": "3001",
        "box_number": null,
        "street_number": "3"
      },
      "old_address": {
        "city": "Leuven",
        "region": "Vlaams Gewest",
        "street": "Gaston Geenslaan",
        "country": "BE",
        "postcode": "3001",
        "box_number": null,
        "street_number": "1"
      },
      "effective_date": "2023-06-19",
      "evidence_quote": "Het bestuursorgaan beslist op 19 juni 2023 een correctie aan te brengen in de notari\u00EBle akte van 9 juni 2023. Het huisnummer van de maatschappelijke zetel van Tavira Therapeutics BV wordt met onmiddellijke ingang gewijzigd naar Gaston Geenslaan 3, 3001 Leuven."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "TAVIRA THERAPEUTICS",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "zetel_clause_amendment_no_move",
      "seat_type": "siege_social",
      "new_address": {
        "raw": "Gaston Geenslaan 3, 3001 Leuven",
        "city": "Leuven",
        "region": "vlaams_gewest",
        "street": "Gaston Geenslaan",
        "country": "BE",
        "postcode": "3001",
        "box_number": null,
        "street_number": "3",
        "locality_suffix": null
      },
      "old_address": {
        "raw": "Gaston Geenslaan 1, 3001 Leuven",
        "city": "Leuven",
        "region": "vlaams_gewest",
        "street": "Gaston Geenslaan",
        "country": "BE",
        "postcode": "3001",
        "box_number": null,
        "street_number": "1",
        "locality_suffix": null
      },
      "effective_date": "2023-06-19",
      "evidence_quote": "",
      "region_changed": false,
      "is_statute_change": false,
      "nationality_change": false,
      "old_address_source": "header_volledig_adres",
      "statute_clause_text": null,
      "statute_article_number": null,
      "effective_date_qualifier": "immediate",
      "statutaire_vs_werkelijke": "werkelijke",
      "linguistic_region_changed": false,
      "court_jurisdiction_changed": false,
      "effective_date_is_approximate": false
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-11-25",
    "filing_date": "2074-11-01",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "enig_aandeelhouder_schriftelijk",
    "date": "2023-06-19",
    "unanimous": null
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "Tavira Therapeutics",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": "MichaEls Management BV",
    "person_name": "Els Henckaerts",
    "org_rep_person_name": null,
    "person_role_at_subject": "Bestuurder"
  },
  "co_filed_documents": []
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "MOEYAERT, Benjamien Roger",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-04-08",
      "evidence_quote": "- als bestuurder ontslagen werd, met ingang van 8 april 2024: de heer MOEYAERT, Benjamien Roger, wonende te 3001 Heverlee (Leuven), Oud-Heverleestraat 24."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "GEERS, Bart",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-04-08",
      "evidence_quote": "- als bestuurder benoemd werd, met ingang van 8 april 2024: de heer GEERS, Bart, wonende te 9111 Belsele (Sint-Niklaas), Ernest Claeslaan 29."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "TAVIRA THERAPEUTICS",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": 815000.0,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 81500,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 10.0
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": 815000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": "Incentive Inschrijvingsrechten",
        "n_new_shares": 9056,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_transfer",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_buyback",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Filip Holvoet",
    "firm_city": null,
    "firm_name": "Notariaat Holvoet, F\u0026T notarisvennootschap",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-04-11",
    "filing_date": "2024-04-09",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-04-08",
    "unanimous": true,
    "under_authorized_capital": true,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "Finvision Bedrijfsrevisoren Antwerpen BV",
    "ibr_number": null,
    "mission_type": "quasi_apport",
    "individual_name": "Karel Nijs"
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "Tavira Therapeutics",
    "legal_form": "B.V.",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition van de akte met de geco\u00F6rdineerde tekst van de statuten en de lijst van de oprichtings en wijzigende akten",
    "verslag van de bedrijfsrevisor en van het bestuursorgaan aangaande de inbreng in natura"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "events": [
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "substantive_delegation",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "MOEYAERT, Benjamien Roger",
        "address": "3001 Heverlee (Leuven), Oud-Heverleestraat 24",
        "birth_date": null,
        "profession": null,
        "birth_place": "Heverlee (Leuven)"
      },
      "reason": "end_of_term",
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-04-08",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "substantive_delegation",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "GEERS, Bart",
        "address": "9111 Belsele (Sint-Niklaas), Ernest Claeslaan 29",
        "birth_date": null,
        "profession": null,
        "birth_place": "Belsele (Sint-Niklaas)"
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": "2024-04-08",
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "gedelegeerd_bestuurder",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "Cambrian BV",
        "address": null,
        "country": null,
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": "Filip Holvoet",
    "firm_city": null,
    "firm_name": "Notariaat Holvoet, F\u0026T notarisvennootschap",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-04-11",
    "filing_date": "2024-04-09",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "buitengewone_algemene_vergadering",
      "date": "2024-04-08",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "Tavira Therapeutics",
    "legal_form": "BV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Filip Holvoet",
    "org_rep_person_name": null,
    "person_role_at_subject": "geassocieerd notaris"
  },
  "co_filed_documents": [
    "Elektronisch: expeditie van de akte met de geco\u00F6rdineerde tekst van de statuten en de lijst van de oprichtings en wijzigende akten",
    "Manueel: verslag van de bedrijfsrevisor en van het bestuursorgaan aangaande de inbreng in natura"
  ],
  "corrected_publication_numac": null
}

{
  "stage": "completed",
  "notary": {
    "name": "Filip Holvoet",
    "firm_city": null,
    "firm_name": "Notariaat Holvoet, F\u0026T notarisvennootschap",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-04-11",
    "filing_date": "2024-04-09",
    "act_kind_objet": "KAPITAAL, AANDELEN, ONTSLAGEN, BENOEMINGEN,"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-04-08",
    "unanimous": true
  },
  "conversion": null,
  "detected_kind": "conversion_legal_form",
  "report_waiver": {
    "summary": "De verplichting tot het verstrekken van verslagen is opgeheven voor de artikelen 5:121, 5:133, 7:179 en 12:26 van het WVV/CSA.",
    "articles": [
      "5:121",
      "5:133",
      "7:179",
      "12:26"
    ]
  },
  "restructuring": {
    "parties": [
      {
        "kbo": "0802.591.262",
        "name": "Tavira Therapeutics",
        "role": "contributor",
        "address": "Gaston Geenslaan 1, 3001 Leuven",
        "is_foreign": false,
        "legal_form": "BV",
        "is_new_company": false,
        "jurisdiction_country": "BE"
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "5:133"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": null,
    "exchange_ratio_text": null,
    "new_shares_issued_n": null,
    "real_estate_included": false,
    "patrimony_description": "De inbreng in Natura betreft de inbreng van een factuur voor een totaalbedrag van 815.000,00 EUR.",
    "equity_transferred_eur": 815000.0,
    "accounting_effective_date": null
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "Tavira Therapeutics",
    "legal_form": "Besloten Vennootschap"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Filip Holvoet",
    "org_rep_person_name": null
  },
  "summary_narrative": "De akte van 8 april 2024 bevestigt dat de buitengewone algemene vergadering van Tavira Therapeutics BV de beschikbare eigen vermogensrekening verhoogde met 815.000,00 EUR. Dit werd gedaan door de uitgifte van 81.500 aandelen, die werden verkregen door een inbreng in natura van een schuldvordering voor 10,00 EUR per aandeel. Het besluit werd goedgekeurd door de Bedrijfsrevisor.",
  "co_filed_documents": [
    "Elektronisch: expeditie van de akte met de geco\u00F6rdineerde tekst van de statuten en de lijst van de oprichtings en wijzigende akten",
    "Manueel: verslag van de bedrijfsrevisor en van het bestuursorgaan aangaande de inbreng in natura"
  ],
  "detected_real_type": "other",
  "referenced_correction": null,
  "should_reroute_to_category": null
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 815000,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 815000,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2024-04-08",
      "evidence_quote": "de beschikbare eigen vermogensrekening van de Vennootschap verhoogd werd met een bedrag van achthonderdvijftienduizend euro (\u20AC 815.000,00) door uitgifte van \u00E9\u00E9nentachtigduizend vijfhonderd (81.500) aandelen, zonder nominale waarde, deelnemend in de winst vanaf hun onderschrijving, vertegenwoordigend \u00E9\u00E9n/honderdachtennegentigduizendste (1/198.000ste) van het vennootschapsvermogen, waarop ingetekend werd door een inbreng in natura van een schuldvordering ontstaan onder een overdrachtovereenkomst aan een uitgifteprijs van tien euro (\u20AC 10,00) per aandeel, welke aandelen voor honderd procent (100%) volgestort werden.",
      "contribution_type": "in_kind"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "TAVIRA THERAPEUTICS",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "amount": 350000.0,
      "currency": "EUR",
      "after_eur": null,
      "delta_eur": 350000.0,
      "before_eur": null,
      "amount_type": "kapitaal_effectief",
      "effective_date": "2023-06-09",
      "evidence_quote": "de beschikbare eigen vermogensrekening verhoogd werd met een bedrag van driehonderdvijftigduizend euro (\u20AC 350.000,00) door uitgifte van vijfendertigduizend (35.000) aandelen, zonder nominale waarde, deelnemend in de winst vanaf hun onderschrijving, ... en waarop ingetekend werd door een inbreng in speci\u00EBn aan een uitgifteprijs van afgerond tien euro (\u20AC 10,00) per aandeel",
      "contribution_type": "cash"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "TAVIRA THERAPEUTICS",
    "legal_form": "BV"
  }
}

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 350000.0,
      "delta_eur": 350000.0,
      "before_eur": 0.0,
      "_arith_derived": "before",
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": null,
        "n_new_shares": 35000,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 10.0
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 350000.0,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "share_emission": {
        "agio_eur": null,
        "share_form": null,
        "share_class": null,
        "n_new_shares": null,
        "with_new_shares": false,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": null
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Tom Holvoet",
    "firm_city": null,
    "firm_name": "Notariaat Holvoet, F\u0026T notarisvennootschap",
    "office_city": "Antwerpen",
    "is_associated": true
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2023-06-20",
    "filing_date": "2023-06-16",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "notarieel_alleen",
    "act_date": "2023-06-09",
    "unanimous": null,
    "under_authorized_capital": false,
    "underlying_resolution_date": null
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "Tavira Therapeutics",
    "legal_form": "B.V.",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "Expeditie van de akte",
    "Geco\u00F6rdineerde tekst van de statuten met de lijst van de oprichtings en wijzigende akten"
  ],
  "shareholders_after": [],
  "share_classes_after": []
}

{
  "kind": "oprichting",
  "seat": "Gaston Geenslaan 1, 3001 Heverlee",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "HENCKAERTS, Els Jeanny Vicky",
        "niss": null,
        "address": "3020 Herent, Brusselsesteenweg 166"
      },
      "share_class": null,
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": null,
      "holder_person_name": "HENCKAERTS, Els Jeanny Vicky",
      "is_subscriber_only": true,
      "n_shares_subscribed": null,
      "amount_subscribed_eur": null,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "BENOY, Veronick",
        "niss": null,
        "address": "3384 Glabbeek-Attenrode, Uilekotstraat 3"
      },
      "share_class": null,
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": null,
      "holder_person_name": "BENOY, Veronick",
      "is_subscriber_only": true,
      "n_shares_subscribed": null,
      "amount_subscribed_eur": null,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "MOEYAERT Benjamien Roger",
        "niss": null,
        "address": "3001 Heverlee (Leuven), Oud-Heverleestraat 24"
      },
      "share_class": null,
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": null,
      "holder_person_name": "MOEYAERT Benjamien Roger",
      "is_subscriber_only": true,
      "n_shares_subscribed": null,
      "amount_subscribed_eur": null,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "VAN HOVE Inge",
        "niss": null,
        "address": "3461 Molenbeek-Wersbeek (Bekkevoort), Leeuwkenstraat 16"
      },
      "share_class": null,
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": null,
      "holder_person_name": "VAN HOVE Inge",
      "is_subscriber_only": true,
      "n_shares_subscribed": null,
      "amount_subscribed_eur": null,
      "is_anonymous_silent_partner": false
    },
    {
      "org": null,
      "kind": "natural_person",
      "person": {
        "dob": null,
        "name": "TAMBOLI Vibha Kiran",
        "niss": null,
        "address": "17 Kingscourt Road, Flat 1, SW16 1JA, Londen (Verenigd Koninkrijk)"
      },
      "share_class": null,
      "partner_role": null,
      "holder_org_kbo": null,
      "holder_org_name": null,
      "contribution_type": "cash",
      "amount_paid_in_eur": null,
      "holder_person_name": "TAMBOLI Vibha Kiran",
      "is_subscriber_only": true,
      "n_shares_subscribed": null,
      "amount_subscribed_eur": null,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 815.0,
  "subject_company": {
    "kbo": "0802.591.262",
    "name_full": "Tavira Therapeutics",
    "legal_form": "BV"
  },
  "initial_directors": [],
  "incorporation_date": "2023-06-09",
  "post_incorporation_mandates": []
}